Given their significant roles, dysregulation of FGF signaling is implicated in various pathological conditions. Overexpression or mutations in FGFs or FGFRs can contribute to oncogenesis, leading to cancers such as breast, prostate, and bladder cancer. Conversely, deficiencies in FGF signaling can result in developmental disorders and impaired wound healing.
